News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
Government minister Lord Prior visits The London Cancer Hub

17/10/17

Transport links in Sutton, and the potential for science to drive economic growth, were two of the themes of a visit by Government minister Lord Prior to The London Cancer Hub.
scientist looking through microscope
Cancer relapse linked to body’s own immune system

16/10/17

Cancer cells that survive after treatment may use the body’s own immune system to wake themselves up and fuel their growth, a new study shows.
MRI brain scan
Breakthrough for advanced head and neck cancer patients as nivolumab made available on the Cancer Drugs Fund

13/10/17

The immunotherapy nivolumab has today been made available on the Cancer Drugs Fund (CDF) for patients with head and neck cancer if the disease progresses within six months of receiving platinum chemotherapy.
Myeloma of sphenoid sinus. Wellcome Images / Creative Commons by-nc-nd 4.0
New myeloma clinical trial launches with aim to transform treatment from one-size-fits-all approach

10/10/17

People with newly diagnosed high risk myeloma will be treated based on the results of genetic testing as part of a new UK-first clinical trial.
ICR Logo
Quick, cheap genetic test could help prostate cancer treatment

10/10/17

Identifying which men with advanced prostate cancer will benefit from targeted treatments could be made easier with a quick and cost-effective test, researchers have found.
t-cell rhs
State of immune system linked to worse survival in biliary tract cancers

06/10/17

The state of the immune system in the area around a biliary tract cancer tumour may be a good indicator of whether the cancer is likely to return following surgery, researchers have found.
Myeloma of sphenoid sinus. Wellcome Images / Creative Commons by-nc-nd 4.0
Overactive gene associated with more aggressive forms of bone marrow cancer myeloma

02/10/17

A gene which is overactive in some cases of myeloma has been linked, for the first time, with more aggressive forms of the disease.
MRI brain scan
Study splits incurable childhood brain tumours into 10 new diseases

28/09/17

Scientists have found that deadly childhood brain tumours are actually 10 different diseases that should each be diagnosed and treated based on their specific genetic faults.
Test Tubes
No evidence for genetic link between height and testicular cancer

27/09/17

There is no evidence being tall causes an increased risk of testicular cancer, according to a new genetic analysis of more than 24,000 men.
Prostate cancer cells
Pioneering ‘precision’ radiotherapy boosts prostate cancer survival

25/09/17

A high-tech form of radiotherapy that shapes radiation beams to tumours can dramatically improve outcomes for patients with prostate cancer, long-term clinical trial results show.
Breast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue)
New treatment approach for rare type of ‘triple negative’ breast cancers identified

22/09/17

Leading scientists funded by Breast Cancer Now have identified a potential new treatment approach for some ‘triple negative’ breast cancers (TNBCs).
blood samples in test tube
Blood test could predict response of HPV-positive head and neck cancer to treatment

21/09/17

Researchers have developed a blood test that can detect whether patients with a type of locally advanced (non-metastatic) head and neck cancer have residual tumours after chemotherapy and radiotherapy.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.